# Commission Regulation (EU) 2015/1041 of 30 June 2015 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (Text with EEA relevance), Annex: Rejected health claims

Extent: E+W+S+N.I.

Application — Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.
Citrulline-malate
Maintenance of ATP levels through reduction of lactates in excess for an improved recovery from muscle fatigue.
Q-2013-00659
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.
Olive (Olea europaea L.) leaf water extract
Daily intake of supplemental olive leaf extract polyphenols contributes to the reduction of the blood glucose rise after meals.
Q-2013-00783
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.
Pacran®
Pacran® helps to inhibit the adhesion of P-fimbriated E. coli to the urinary tract cells.
Q-2013-00889
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.
A combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104
Improves intestinal comfort.
Q-2013-00892
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.
A combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104
Regulates your (intestinal) transit.
Q-2013-00893
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.
A combination of L-threonine, L-valine, L-leucine, L-isoleucine, L-lysine plus chromium picolinate
Contributes to the reduction of the blood glucose rise when consumed together with a carbohydrate rich meal.
Q-2013-00756
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data.
A combination of lutein and zeaxanthin
Lutein together with zeaxanthin helps maintain clarity and contrast of sight in bright light conditions.
Q-2013-00875

---
Source: https://www.legislation.gov.uk/eur/2015/1041/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2015-1041/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.